Owp Drug Patent Portfolio

Owp owns 1 orange book drug protected by 2 US patents Given below is the list of Owp's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11596634 Lamotrigine Oral Liquid Suspension And Use Thereof 29 May, 2040
Active
US11612566 Lamotrigine Oral Liquid Suspension And Use Thereof 29 May, 2040
Active


Given below is the list of recent legal activities going on the following drug patents of Owp.

Activity Date Patent Number
Patent litigations
Patent Issue Date Used in PTA Calculation 28 Mar, 2023 US11612566
Recordation of Patent Grant Mailed 28 Mar, 2023 US11612566
Issue Notification Mailed 08 Mar, 2023 US11612566
Patent Issue Date Used in PTA Calculation 07 Mar, 2023 US11596634
Recordation of Patent Grant Mailed 07 Mar, 2023 US11596634
Dispatch to FDC 24 Feb, 2023 US11612566
Application Is Considered Ready for Issue 24 Feb, 2023 US11612566
Issue Fee Payment Received 20 Feb, 2023 US11612566
Issue Notification Mailed 15 Feb, 2023 US11596634
Application Is Considered Ready for Issue 02 Feb, 2023 US11596634
Dispatch to FDC 02 Feb, 2023 US11596634
Issue Fee Payment Received 01 Feb, 2023 US11596634
Issue Fee Payment Verified 01 Feb, 2023 US11596634
Mail Notice of Allowance 21 Nov, 2022 US11612566
Issue Fee Payment Verified 21 Nov, 2022 US11612566


Owp's Family Patents


Family Patents



Owp Drug List

Given below is the complete list of Owp's drugs and the patents protecting them.


1. Subvenite

Subvenite is protected by 2 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11596634 Lamotrigine Oral Liquid Suspension And Use Thereof 29 May, 2040
(14 years from now)
Active
US11612566 Lamotrigine Oral Liquid Suspension And Use Thereof 29 May, 2040
(14 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Subvenite's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List